KETOPROFENE TEVA LP 100 mg, scored tablet with extended release 20 tablets
Active ingredients: KÉTOPROFÈNE
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet with extended release20 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- KETOPROFENE TEVA LP 100 mg, comprimé sécable à libération prolongée
- Pharmaceutical form
- comprimé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 20 comprimé(s)
- Marketing authorisation holder
- TEVA SANTE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 18 Sept 2013
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63114896CIP72214283CIP133400922142838Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| KÉTOPROFÈNEcomprimé | 100 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: KETOPROFENE 100 mg - BI PROFENID LP 100 mg, comprimé sécable à libération prolongée.